Not to hype a stock here lol, but one stock to keep an eye on over the short term is MBRX trading under $3. When trials begin on Annamycin for the treatment of Leukemia in around the next 45 days, you would think MBRX would trade in the $15 - $20 level "to start" as similar companies are now. Could be one to hold for awhile. This drug is crucial for treating leukemia patients in receiving a bone marrow transplant, which is usually required for survival. That drug by MBRX is drastically needed. Leukemia is a monster, and I know first hand. Always do your own research though!
Also important to note -- similar pharma stocks with a lot let promise are currently trading in the $12 - $20 range, and MBRX stock is so volatile, that they've even had to pause trading, lol. It's extremely explosive with a very high upside. Could be one to ride out.
Best of luck to all! |
